Antiretroviral News and Research

RSS

Study connects food insecurity to mental health in young mothers

A new review of research from across sub-Saharan Africa found that inadequate access to food is linked to depression, suicide attempts, HIV vulnerabilities, and poorer sexual and reproductive health outcomes among adolescent mothers.

30 Sep 2026

HIV awareness emphasizes prevention, treatment and healthy aging

About 1.2 million people in the United States are living with HIV, or human immunodeficiency virus. Because of major advances in medical treatment and technology, people with HIV are living long, healthy lives.

18 Sep 2026

Antibody therapy teaches the immune system to control HIV

There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives.

18 Sep 2026

Eight-weekly HIV injections prove more effective than daily tablets for young people

Young people living with HIV manage their condition better when their antiretroviral therapy is given by injections every eight weeks, rather than in the form of daily tablets, according to the results of a trial in Africa led by UCL (University College London) researchers.

17 Sep 2026

Cancer drug eliminates HIV-infected cells in animal model study

Emory University researchers have provided the first proof-of-concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved medication for cancer.

3 Sep 2026

Brain organoid studies on the ISS move closer to new treatments

Research using human brain organoids onboard the International Space Station International Space Station (ISS) helped lead to the clinical trial of a potential therapy for Rett syndrome, a debilitating neurological disorder in children.

20 Aug 2026

New combination therapy could permanently clear HIV in newborns

Every year, more than 120,000 newborns worldwide contract HIV, a global health burden that requires lifelong treatment for millions of people - assuming they have access and can afford it.

10 Aug 2026

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.

5 Aug 2026

Biotherapeutic metabolite repairs gut damage caused by HIV infection

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in the nonhuman primate model of HIV/AIDS.

30 Jul 2026

Once-weekly oral tablet proves highly effective for HIV care

An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as one of today's leading daily therapies, offering the potential for a new treatment option that could reduce the burden of lifelong daily pill-taking.

29 Jul 2026

Tracking Lassa fever survivors provides crucial clues for future vaccines

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the launch of a research study to understand how Lassa fever survivors fight and overcome Lassa virus infection.

14 Jul 2026

New vaccines successfully boost frontline immune cells against HIV

T-cells are the immune system's frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial published in the Journal of Clinical Investigation, researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID) at the UNC School of Medicine have demonstrated that new vaccines can significantly boost T cells targeting the most vulnerable, conserved regions of HIV-areas considered key to effective immune control.

22 Jun 2026

NYU Langone performs the world's first HIV-positive-to-HIV-positive lung transplant

The world's first HIV-positive-to-HIV-positive lung transplant was performed at NYU Langone Health.

19 Jun 2026

Semaglutide, omega-3s and diet shift epigenetic aging clocks in human studies

A systematic review identified 41 human studies evaluating interventions targeting next-generation DNA methylation-based aging clocks. Pharmaceutical, lifestyle, supplement, clinical, and psychosocial interventions shifted some clock outputs, but these biomarkers remain investigational rather than proven clinical surrogates.

16 Jun 2026

Defective HIV copies explain persistent viral traces during treatment

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives.

8 Jun 2026

Flu drugs may reduce cognitive decline in people with HIV

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials.

5 Jun 2026

New index identifies HIV prevention gaps across the Southern United States

The University of Mississippi-led study, published in Frontiers in Public Health, offers health care and government leaders a new tool for targeting HIV-related support where the need is highest.

3 Jun 2026

GLP-1 therapy linked to slower biological aging processes

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease.

2 Jun 2026

Tulane study explains why gut damage persists despite HIV treatment

For many people living with HIV, today's treatments can suppress the virus and dramatically improve health. But even when HIV is controlled, damage to the gut caused by the disease can persist, fueling chronic inflammation linked to serious health problems.

22 May 2026

Surgical training program for community health officers slashes maternal mortality risk

Maternal mortality in Sierra Leone used to be among the highest in the world. A 15-year-old non-profit program that trains community health officers to do life-saving surgeries has helped slash that risk by two-thirds.

18 May 2026